Report Feature
The future of the neuroscience antibody and assay market looks promising with opportunities in the pharmaceutical and biotechnology companies, academic & research institutes, and hospitals & diagnostic centers. The global neuroscience antibody and assay market is expected to grow with a CAGR of 9%-11% from 2020 to 2025. The major drivers for this market are increasing neurological diseases and rising investments in neuroscience research.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global neuroscience antibody and assay market report, please download the report brochure.
In this market, consumables and reagents is the largest product type of neuroscience antibody and assay, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the neuroscience antibody and assay market are given below:
The study includes trends and forecast for the global neuroscience antibody and assay market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Consumables and Reagents
- Instruments
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Immunochemistry/Immunoassays
- Molecular Diagnostics
- Clinical Chemistry
- Other Technologies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Research
- In Vitro Diagnostics
- Drug Discovery and Development
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the neuroscience antibody and assay model companies profiled in this report include Thermo Fisher Scientific, Abcam, Merck, Siemens, Cell Signaling Technology, F. Hoffmann-La Roche, GenScript, and BioLegend.
Lucintel forecasts that consumables and reagents segment will remain the largest product segment over the forecast period due to consistent usage of consumables and their frequent demand, and rising government initiatives in the Genomics and Proteomics research sector.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to the high uptake of neuroscience antibodies in the drug discovery and development process.
North America will remain the largest region over the forecast period due to increasing investments for the development of structure-based drug designs, growing research in the field of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, and the focus of stakeholders on research projects involving proteins, associated biomolecules, and genes.
|
Features of the Global Neuroscience Antibody and Assay Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global neuroscience antibody and assay market by product (consumables and reagents and instruments), technology (immunochemistry/immunoassays, molecular diagnostics, clinical chemistry, and other technologies), application (research, in vitro diagnostics, drug discovery and development), end user (pharmaceutical & biotechnology companies, academic & research institutes and hospitals & diagnostic centers), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global neuroscience antibody and assay market? Q.5 What are the business risks and threats to the global neuroscience antibody and assay market? Q.6 What are the emerging trends in this neuroscience antibody and assay market and the reasons behind them? Q.7 What are some changing demands of customers in this neuroscience antibody and assay market? Q.8 What are the new developments in this neuroscience antibody and assay market? Which companies are leading these developments? Q.9 Who are the major players in this neuroscience antibody and assay market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this neuroscience antibody and assay market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global neuroscience antibody and assay market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Consumables and Reagents and Instruments), Technology (Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies), Application (Research, In Vitro Diagnostics, Drug Discovery and Development), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Hospitals & Diagnostic Centers) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Neuroscience Antibody and Assay Market
4.1 Global Neuroscience Antibody and Assay Market by Region
4.2.1 Market by Product: Consumables and Reagents and Instruments
4.2.2 Market by Technology: Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies
4.2.3 Market by Application: Research, In Vitro Diagnostics, Drug Discovery and Development
4.2.4 Market by End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers
4.2.5 The United States Neuroscience Antibody and Assay Market
4.2.6 The Canadian Neuroscience Antibody and Assay Market
4.2.7 The Mexican Neuroscience Antibody and Assay Market
4.3.1 Market by Product: Consumables and Reagents and Instruments
4.3.2 Market by Technology: Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies
4.3.3 Market by Application: Research, In Vitro Diagnostics, Drug Discovery and Development
4.3.4 Market by End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers
4.3.5 The United Kingdom Neuroscience Antibody and Assay Market
4.3.6 The Spanish Neuroscience Antibody and Assay Market
4.3.7 The German Neuroscience Antibody and Assay Market
4.3.8 The French Neuroscience Antibody and Assay Market
4.4.1 Market by Product: Consumables and Reagents and Instruments
4.4.2 Market by Technology: Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies
4.4.3 Market by Application: Research, In Vitro Diagnostics, Drug Discovery and Development
4.4.4 Market by End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers
4.4.5 The Chinese Neuroscience Antibody and Assay Market
4.4.6 The Indian Neuroscience Antibody and Assay Market
4.4.7 The Japanese Neuroscience Antibody and Assay Market
4.5.1 Market by Product: Consumables and Reagents and Instruments
4.5.2 Market by Technology: Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, and Other Technologies
4.5.3 Market by Application: Research, In Vitro Diagnostics, Drug Discovery and Development
4.5.4 Market by End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers
4.5.5 Brazilian Neuroscience Antibody and Assay Market
7.1.1 Growth Opportunities for the Global Neuroscience Antibody and Assay Market by Product
7.1.2 Growth Opportunities for the Global Neuroscience Antibody and Assay Market by Technology
7.1.3 Growth Opportunities for the Global Neuroscience Antibody and Assay Market by Application
7.1.4 Growth Opportunities for the Global Neuroscience Antibody and Assay Market by End User
7.1.5 Growth Opportunities for the Global Neuroscience Antibody and Assay Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
